Abstract:Multiple myeloma (MM) is an incurable B-cell malignancy. High-dose chemotherapy with stem cell support has achieved higher response rates than conventional therapy, but few patients remain in long-term remission. Arsenic trioxide (As2O3) is an effective treatment for acute promyelocytic leukemia. Current clinical studies are investigating arsenic as a therapeutic agent for malignancies. The mechanism of cytotoxicity inducted by As2O3 has not been known thoroughly. Constitutively activated NF-κB is a characteristic of different tumor entities including MM clones and malignant plasma cells from MM patients. It plays an important role in maintaining tumor cell proliferation and protecting cell from apoptosis. The study was to explore the possible mechanism of As2O3 effects on MM lines. Materials and methods: The human MM cell lines of KM3 and RPMI8226 were provided by Hematology Institution of Zhejiang University. The concentration of As2O3 in cell culture system was from 0.5μmol/L to 20μmol/L, 24 hours was selected as the termination point of cell culture. Cell culture without As2O3 and first-antibody-dismissed test were enrolled as controls. Both of the MM lines were treated with As2O3 in various concentrations. The restrained proliferation was observed by drawing growth curve. MTT bioassay was used to examine the effect of As2O3 on cell growth and the concentration of 50% growth inhibition( IC50) calculated respectively. Apoptosis and changes of IκB-α protein was observed by flow cytometry(FCM). Changes and subcellular localization of IκB-α protein were observed by fluorescence microscopy. Western blot was also used to analyze the expression of NF-κB in nuclear. Results: As2O3 inhibited the proliferation of both MM lines, and IC50 of KM3 and RPMI8226 was 9.61μmol/L and 8.01μmol/L respectively. After exposure to As2O3, both of the lines were induced to apoptosis. With As2O3 concentration varied from 0.5μmol/L to 20μmol/L the apoptosis rate of KM3 and RPMI8226 was concentration-dependent measured by FCM. After 24 hours treated with 20μmol/L As2O3, the apoptosis rate of KM3 cells was 41.18% while that of RPMI8226 was 65.25%. It seemed that RPMI8226 cell was more sensitive to As2O3. FCM analysis showed a significant increase in the percentage of G2/M phase cells, from 13.74% to 41.72%, and a decrease percentage of S phase cells from 35.11% to 23.96%. The level of IκB-α in cytoplasm was down-regulated after As2O3 stimulation in both cell lines. The down-regulation of IκB-α from 79.68% to 51.57% was confirmed by FCM in KM3 treated with 10μmol/L As2O3 (p<0.01), the effect was concentration-dependent. While the IκB-α in RPMI8226 changed from 79.72% to 34.08% (p<0.01). Immunofluorescence assay showed that IκB-α localized in cytoplasm mostly. The level of IκB-α protein was down-regulated after As2O3 stimulation. The results showed that KM3 and RPMI8226 lines expressed constitutively activity NF-κB and As2O3 down-regulated the constitutive expression of NF-κB in both cell lines but with different kinetics. Conclusions: As2O3 could not only inhibit the proliferation but also induce apoptosis of KM3 and RPMI8226 cells. The mechanisms of its effect on MM cells may include decreasing the constitutive activity of NF-κB, subsequently down-regulating the expression of various gene products controlled by NF-κB, thus inducing apoptosis in MM cells. As2O3 could inhibit the proliferation of MM cells by changing MM cell cycle and inducing G2/M phase arrest.

[The Heat Shock Protein 90 Inhibitor Induces Apoptosis and Differentiation of Kasumi-1 and Its Mechanisms].

Heat shock protein 90 inhibition results in altered downstream signaling of mutant KIT and exerts synergistic effects on Kasumi-1 cells when combining with histone deacetylase inhibitor

The Hsp90 Inhibitor 17-Allylamide-17-demethoxygeldanamycin Induces Apoptosis and Differentiation of Kasumi-1 Harboring the Asn822Lys KIT Mutation and Down-Regulates KIT Protein Level

[Study on Signal Transduction Pathway in Differentiation and Apoptosis of Leukemia Cells Induced by Heat Shock Protein Inhibitor].

[Effect of Homoharringtonine Combined with AG490 on JAK2-STAT5 Associated Signal Pathway in HEL Cells].

[ITF-2357 on Inhibition Myeloid Leukemic Cell Lines Cells Proliferation in Vitro and Its Mechanism].

Homoharringtonine Affects the Jak2-Stat5 Signal Pathway Through Alteration of Protein Tyrosine Kinase Phosphorylation in Acute Myeloid Leukemia Cells

Mechanism Of Arsenic Trioxide-Induced Apoptosis On Multiple Myeloma Cells.

Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin inhibits the proliferation of ARPE-19 cells

Influence of 17AAG on proliferation and invasion of gastric cancer cell and its mechanism

[Effect of Tyrosine Kinase Inhibitor Imatinib Mesylate on Proliferation, Differentiation and Apoptosis of Kasumi-1 Leukemia Cell Line].

17-AAG Induces Endoplasmic Reticulum Stress-mediated Apoptosis in Breast Cancer Cells, Possibly Through PERK/eIF2α Up-regulation

[Effect of AMPK Agonist 5-Aminoimidazole-4-carboxamide Ribonucleoside on Proliferation, Differentiation and Apoptosis in U937 Cells].

17-Abag, A Novel Geldanamycin Derivative, Inhibits Lncap-Cell Proliferation Through Heat Shock Protein 90 Inhibition

Effect of Phenylbutyrate, a Histone Deacetylase Inhibitor, on Differentiation and Apoptosis of Kasumi-1 Cells

Geldanamycin, a Heat Shock Protein 90‐binding Agent, Disrupts Stat5 Activation in IL‐2‐stimulated Cells

Inhibitory effect of 17AAG on proliferation and invasion of hepatocellular carcinoma cells

HDN-1 induces cell differentiation toward apoptosis in promyelocytic leukemia cells depending on its selective effect on client proteins of Hsp90

Effect of 17-allylaminogeldanamycin on antimicrobial peptide and cytokine expression in HaCaT cells after IL-17 and heat stimuli (MUC2P.941)

Astilbic Acid Induced COLO 205 Cell Apoptosis by Regulating Bcl-2 and Bax Expression and Activating Caspase-3.

Death and apoptosis of LAK cell during immunologic assault and the rescuing effects of approaches